Shigeru Handa

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Berkshire Partners LLC (Berkshire Partners) is a private equity subsidiary of Berkshire Partners Holdings LLC founded in 1986 by Christopher Clifford, Carl Ferenbach, Russel L. Epker, Brad Bloom and Richard Lubin. The firm is headquartered in Boston, Massachusetts.

Satellite Healthcare, Inc. is a non-profit, community benefit organization that provides medical services to patients with chronic kidney disease. The company operates dialysis center and provides training and support for patients performing dialysis at home. It also offers pre-dialysis patient wellness education programs that can help prevent or slow the progression of early stage chronic kidney disease. It was founded by Norman S. Coplon in 1973 and is headquartered in San Jose, CA.

Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY.

Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA.

KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.

Nephrocare Health Services Pvt Ltd. operates a chain of kidney care clinics. Its services include in-centre hemodialysis, home hemodialysis, dialysis on wheels, and holiday dialysis. The company was founded by Vikram Vuppala, Sandeep Gudibanda, and Kamal D. Shah on December 18, 2009 and is headquartered in Hyderabad, India.

Opsonix, Inc. manufactures and distributes medical devices. It commercializes and develops products to transform the treatment and diagnosis of sepsis. The company was founded on April 11, 2014 and is headquartered in Cambridge, MA.

ProKidney LLC develops therapies for kidney disease. The company was founded by Pablo Legorreta and is headquartered in Winston-Salem, NC.

Flint Atlantic Capital (Flint Atlantic Capital) is a private equity/ venture capital firm founded in 2016. The firm is headquartered in South Africa.

Part of Otsuka Holdings Co., Ltd., Cullinan Pearl Corp. is a company that develops an orally available tyrosine kinase inhibitor. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. Cullinan Pearl was acquired by Taiho Pharmaceutical Co., Ltd. from Cullinan Oncology, Inc. on June 23, 2022 for $405 million.